Production (Stage)
Caris Life Sciences, Inc.
CAI
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.43M | 121.59M | |||
| Total Receivables | 80.17M | -- | |||
| Inventory | 36.55M | -- | |||
| Prepaid Expenses | 11.92M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 9.16M | -- | |||
| Total Current Assets | 171.23M | -- | |||
|
|
|||||
| Total Current Assets | 171.23M | -- | |||
| Net Property, Plant & Equipment | 61.65M | -- | |||
| Long-term Investments | 19.34M | -- | |||
| Goodwill | 19.34M | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 39.36M | -- | |||
| Total Assets | 291.58M | -- | |||
|
|
|||||
| Total Accounts Payable | 24.23M | -- | |||
| Total Accrued Expenses | 64.55M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 66.12M | -- | |||
| Total Finance Division Other Current Liabilities | 7.66M | -- | |||
| Total Other Current Liabilities | 7.66M | -- | |||
| Total Current Liabilities | 162.55M | -- | |||
|
|
|||||
| Total Current Liabilities | 162.55M | -- | |||
| Long-Term Debt | 316.40M | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 37.31M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 129.07M | -- | |||
| Total Liabilities | 645.34M | -- | |||
|
|
|||||
| Common Stock & APIC | 145.00K | -- | |||
| Retained Earnings | -2.58B | -- | |||
| Treasury Stock & Other | -16.67M | -- | |||
| Total Common Equity | -2.60B | -2.14B | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 2.25B | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 2.25B | 2.13B | |||
|
|
|||||
| Total Common Equity | -2.60B | -2.14B | |||
| Total Preferred Equity | 2.25B | 2.13B | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -353.75M | -19.67M | |||
|
|
|||||